Is there value in alvimopan in minimally invasive colorectal surgery?

American Journal of Surgery

Volumn 212, Issue 5, 2016, Pages 851-856

  Keller, Deborah S ^a,b   Flores Gonzalez, Juan Ramon ^a   Ibarra, Sergio ^a   Mahmood, Ali ^a,b,c   Haas, Eric M ^a,b,c  

^a LLP   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Alvimopan; Enhanced recovery after surgery; Health care outcomes; Laparoscopic colorectal surgery; Postoperative ileus

Indexed keywords

ALVIMOPAN; ANALGESIC AGENT; GASTROINTESTINAL AGENT; PIPERIDINE DERIVATIVE;

ABDOMINAL ABSCESS; ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; BLOOD TRANSFUSION; CANCER PATIENT; CANCER SURGERY; CLINICAL EVALUATION; CLINICAL OUTCOME; CLINICAL PATHWAY; COHORT ANALYSIS; COLON CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DEHYDRATION; DRUG COST; ENHANCED RECOVERY PATHWAY; FEMALE; HOSPITAL COST; HOSPITAL READMISSION; HUMAN; LAPAROSCOPIC SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; OPERATION DURATION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE ILEUS; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REOPERATION; SMALL INTESTINE OBSTRUCTION; STOMA; SURGICAL INFECTION; SURGICAL PATIENT; ADVERSE EFFECTS; AGED; COMPARATIVE STUDY; CONVALESCENCE; ECONOMICS; ELECTIVE SURGERY; EVALUATION STUDY; FACTUAL DATABASE; FOLLOW UP; ILEUS; LAPAROSCOPY; NONPARAMETRIC TEST; POSTOPERATIVE COMPLICATIONS; PROCEDURES; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME;

AGED; COLORECTAL SURGERY; COST-BENEFIT ANALYSIS; DATABASES, FACTUAL; ELECTIVE SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HUMANS; ILEUS; LAPAROSCOPY; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; PIPERIDINES; POSTOPERATIVE COMPLICATIONS; RECOVERY OF FUNCTION; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84973912652     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2016.02.016     Document Type: Article

References (40)

1. 1 Barletta, J.F., Senagore, A.J., Reducing the burden of postoperative ileus: evaluating and implementing an evidence-based strategy. World J Surg 38 (2014), 1966–1977.
2. 2 Carroll, J., Alavi, K., Pathogenesis and management of postoperative ileus. Clin Colon Rectal Surg 22 (2009), 47–50.
3. 3 Woods MS. Postoperative Ileus: Dogma Versus Data From Bench to Bedside. Perspect Colon Rectal Surg. 12 f.
4. 4 Asgeirsson, T., El-Badawi, K.I., Mahmood, A., et al. Postoperative ileus: it costs more than you expect. J Am Coll Surg 210 (2010), 228–231.
5. 5 Chang, S.S., Baumgartner, R.G., Wells, N., et al. Causes of increased hospital stay after radical cystectomy in a clinical pathway setting. J Urol 167 (2002), 208–211.
6. 6 Delaney, C.P., Senagore, A.J., Viscusi, E.R., et al. Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: pooled analysis of placebo data from 3 randomized controlled trials. Am J Surg 191 (2006), 315–319.
7. 7 Senagore, A.J., Pathogenesis and clinical and economic consequences of postoperative ileus. Am J Health Syst Pharm 64 (2007), S3–S7.
8. 8 Basse, L., Hjort Jakobsen, D., Billesbolle, P., et al. A clinical pathway to accelerate recovery after colonic resection. Ann Surg 232 (2000), 51–57.
9. 9 Kehlet, H., Wilmore, D.W., Multimodal strategies to improve surgical outcome. Am J Surg 183 (2002), 630–641.
10. 10 Kehlet, H., Postoperative ileus–an update on preventive techniques. Nat Clin Pract Gastroenterol Hepatol 5 (2008), 552–558.
11. 11 Kehlet, H., Wilmore, D.W., Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 248 (2008), 189–198.
12. 12 Lassen, K., Soop, M., Nygren, J., et al. Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. Arch Surg 144 (2009), 961–969.
13. 13 Delaney, C.P., Zutshi, M., Senagore, A.J., et al. Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum 46 (2003), 851–859.
14. 14 Adamina, M., Kehlet, H., Tomlinson, G.A., et al. Enhanced recovery pathways optimize health outcomes and resource utilization: a meta-analysis of randomized controlled trials in colorectal surgery. Surgery 149 (2011), 830–840.
15. 15 Fierens, J., Wolthuis, A.M., Penninckx, F., et al. Enhanced recovery after surgery (ERAS) protocol: prospective study of outcome in colorectal surgery. Acta Chir Belg 112 (2012), 355–358.
16. 16 Gustafsson, U.O., Scott, M.J., Schwenk, W., et al. Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations. Clin Nutr 31 (2012), 783–800.
17. 17 Haverkamp, M.P., de Roos, M.A., Ong, K.H., The ERAS protocol reduces the length of stay after laparoscopic colectomies. Surg Endosc 26 (2012), 361–367.
18. 18 Cakir, H., van Stijn, M.F., Lopes Cardozo, A.M., et al. Adherence to enhanced recovery after surgery and length of stay after colonic resection. Colorectal Dis 15 (2013), 1019–1025.
19. 19 Vaughan-Shaw, P.G., Fecher, I.C., Harris, S., et al. A meta-analysis of the effectiveness of the opioid receptor antagonist alvimopan in reducing hospital length of stay and time to GI recovery in patients enrolled in a standardized accelerated recovery program after abdominal surgery. Dis Colon Rectum 55 (2012), 611–620.
20. 20 Entereg Initial Rems Approval. Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm129511.pdf. Accessed October 2014.
21. 21 Liu, S.S., Hodgson, P.S., Carpenter, R.L., et al. ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia. Clin Pharmacol Ther 69 (2001), 66–71.
22. 22 Bell, T.J., Poston, S.A., Kraft, M.D., et al. Economic analysis of alvimopan in North American Phase III efficacy trials. Am J Health Syst Pharm 66 (2009), 1362–1368.
23. 23 Poston, S., Broder, M.S., Gibbons, M.M., et al. Impact of alvimopan (entereg) on hospital costs after bowel resection: results from a large inpatient database. P T 36 (2011), 209–220.
24. 24 Harbaugh, C.M., Al-Holou, S.N., Bander, T.S., et al. A statewide, community-based assessment of alvimopan's effect on surgical outcomes. Ann Surg 257 (2013), 427–432.
25. 25 Delaney, C.P., Wolff, B.G., Viscusi, E.R., et al. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies. Ann Surg 245 (2007), 355–363.
26. 26 Ludwig, K., Viscusi, E.R., Wolff, B.G., et al. Alvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooled responder analysis. World J Surg 34 (2010), 2185–2190.
27. 27 Wolff, B.G., Michelassi, F., Gerkin, T.M., et al. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg 240 (2004), 728–734 discussion 734–5.
28. 28 Viscusi, E.R., Goldstein, S., Witkowski, T., et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study. Surg Endosc 20 (2006), 64–70.
29. 29 Obokhare, I.D., Champagne, B., Stein, S.L., et al. The effect of alvimopan on recovery after laparoscopic segmental colectomy. Dis Colon Rectum 54 (2011), 743–746.
30. 30 Touchette, D.R., Yang, Y., Tiryaki, F., et al. Economic analysis of alvimopan for prevention and management of postoperative ileus. Pharmacotherapy 32 (2012), 120–128.
31. 31 Barletta, J.F., Asgeirsson, T., El-Badawi, K.I., et al. Introduction of alvimopan into an enhanced recovery protocol for colectomy offers benefit in open but not laparoscopic colectomy. J Laparoendosc Adv Surg Tech A 21 (2011), 887–891.
32. 32 Marderstein, E.L., Delaney, C.P., Management of postoperative ileus: focus on alvimopan. Ther Clin Risk Manag 4 (2008), 965–973.
33. 33 Kelley, S.R., Wolff, B.G., Lovely, J.K., et al. Fast-track pathway for minimally invasive colorectal surgery with and without alvimopan (Entereg): which is more cost-effective?. Am Surg 79 (2013), 630–633.
34. 34 Itawi, E.A., Savoie, L.M., Hanna, A.J., et al. Alvimopan addition to a standard perioperative recovery pathway. JSLS 15 (2011), 492–498.
35. 35 Delaney, C.P., Craver, C., Gibbons, M.M., et al. Evaluation of clinical outcomes with alvimopan in clinical practice: a national matched-cohort study in patients undergoing bowel resection. Ann Surg 255 (2012), 731–738.
36. 36 Simorov, A., Thompson, J., Oleynikov, D., Alvimopan reduces length of stay and costs in patients undergoing segmental colonic resections: results from multicenter national administrative database. Am J Surg 208 (2014), 919–925 discussion 925.
37. 37 Delaney, C.P., Weese, J.L., Hyman, N.H., et al. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery. Dis Colon Rectum 48 (2005), 1114–1125 discussion 1125-6; author reply 1127–9.
38. 38 Red Book Online [database online]. Greenwood Village, CO. Available at: http://www.micromedexsolutions.com/home/dispatch. Accessed March 12, 2015.
39. 39 Whitehead, W.E., Bradley, C.S., Brown, M.B., et al. Gastrointestinal complications following abdominal sacrocolpopexy for advanced pelvic organ prolapse. Am J Obstet Gynecol 197 (2007), 78.e1–78.e7.
40. 40 Augestad, K.M., Delaney, C.P., Postoperative ileus: impact of pharmacological treatment, laparoscopic surgery and enhanced recovery pathways. World J Gastroenterol 16 (2010), 2067–2074.